Previous 10 | Next 10 |
February 19, 2020 Palm Beach, FL – February 19, 2020 – While we should all be diligent in cancer detection and treatment in every month of the year, February is well known as National Cancer Prevention Month. It’s an annual campaign to increase awareness of ...
BUFFALO, N.Y., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer, today announced that it will release fourth quarter and full year ...
BUFFALO, N.Y., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Today, Dr. Johnson Lau, Chairman and Chief Executive Officer of Athenex, Inc. (Nasdaq: ATNX), informed shareholders he received a notice of a proposed administrative fine of RMB 100,000 (approximately $14,300) from the China Securities R...
"It is hard to imagine a more stupid or more dangerous way of making decisions than by putting those decisions in the hands of people who pay no price for being wrong ." - Thomas Sowell Today, we look at a somewhat controversial name in the oncology space. The stock is volatile and has se...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Shares of Athenex ( ATNX ) have risen by 26% since my October 5th article suggested that the stock was a Buy ahead of a key data presentation at SABCS (San Antonio Breast Cancer Symposium). It's no secret that I am a fan of platform technology stories, and here the company's promising phase ...
Having once traded on the AMEX at $20 per share and viewed as an innovative company with a novel technology designed to aid in developing controlled release and abuse-resistant opioids, the competitive environment dramatically changed for Elite Pharma ( ELTP ). Ultimately, their share price dr...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Athenex ( ATNX ) stock tumbled as it released pivotal trial results for its lead drug candidate, an experimental combination treatment for metastatic breast cancer. The Phase 3 trial tested oral paclitaxel along with encequidar, an inhibitor that aims to make chemotherapies more effective. T...
Athenex (NASDAQ: ATNX ) has expanded its strategic partnership with Chinese drug company, Guangzhou Xiangxue Pharmaceutical Co., Ltd., to exclusively develop and commercialize Athenex’s Oral Paclitaxel (both the capsule and the tablet formulations), Oral Irinotecan, as well as Tirba...
News, Short Squeeze, Breakout and More Instantly...
Athenex Inc. Company Name:
ATNX Stock Symbol:
NASDAQ Market:
To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and Fulfill APD Customer Orders During Process BUFFALO, N.Y., May 14, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX) (...
Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO PR Newswire SAN FRANCISCO , May 1, 2023 /PRNewswire/ -- Quantum Leap Healthcare Collaborative (Quantum Leap) and At...
Exploring a range of strategic alternatives Revenues from product sales from continued operations increased +27% Y/Y in 4Q 2022 and +33% for full year 2022 Net Loss attributable to Athenex was $34.2 million, or $4.28 per diluted share in 4Q2022, compared to $104.4 million, or $1...